Works matching IS 19466234 AND DT 2019 AND VI 11 AND IP 475

Results: 5

An engineered E. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans.
Published in:
Science Translational Medicine, 2019, v. 11, n. 475, p. N.PAG, doi. 10.1126/scitranslmed.aau7975
By:
- Kurtz, Caroline B.;
- Millet, Yves A.;
- Puurunen, Marja K.;
- Perreault, Mylène;
- Charbonneau, Mark R.;
- Isabella, Vincent M.;
- Kotula, Jonathan W.;
- Antipov, Eugene;
- Dagon, Yossi;
- Denney, William S.;
- Wagner, David A.;
- West, Kip A.;
- Degar, Andrew J.;
- Brennan, Aoife M.;
- Miller, Paul F.
Publication type:
Article
Targeting hepatic glucokinase to treat diabetes with TTP399, a hepatoselective glucokinase activator.
Published in:
Science Translational Medicine, 2019, v. 11, n. 475, p. N.PAG, doi. 10.1126/scitranslmed.aau3441
By:
- Vella, Adrian;
- Freeman, Jennifer L. R.;
- Dunn, Imogene;
- Keller, Kit;
- Buse, John B.;
- Valcarce, Carmen
Publication type:
Article
Clinical-grade stem cell–derived retinal pigment epithelium patch rescues retinal degeneration in rodents and pigs.
Published in:
Science Translational Medicine, 2019, v. 11, n. 475, p. N.PAG, doi. 10.1126/scitranslmed.aat5580
By:
- Sharma, Ruchi;
- Khristov, Vladimir;
- Rising, Aaron;
- Jha, Balendu Shekhar;
- Dejene, Roba;
- Hotaling, Nathan;
- Li, Yichao;
- Stoddard, Jonathan;
- Stankewicz, Casey;
- Wan, Qin;
- Zhang, Connie;
- Campos, Mercedes Maria;
- Miyagishima, Kiyoharu J.;
- McGaughey, David;
- Villasmil, Rafael;
- Mattapallil, Mary;
- Stanzel, Boris;
- Qian, Haohua;
- Wong, Wai;
- Chase, Lucas
Publication type:
Article
Tuberculosis following PD-1 blockade for cancer immunotherapy.
Published in:
Science Translational Medicine, 2019, v. 11, n. 475, p. N.PAG, doi. 10.1126/scitranslmed.aat2702
By:
- Barber, Daniel L.;
- Sakai, Shunsuke;
- Kudchadkar, Ragini R.;
- Fling, Steven P.;
- Day, Tracey A.;
- Vergara, Julie A.;
- Ashkin, David;
- Cheng, Jonathan H.;
- Lundgren, Lisa M.;
- Raabe, Vanessa N.;
- Kraft, Colleen S.;
- Nieva, Jorge J.;
- Cheever, Martin A.;
- Nghiem, Paul T.;
- Sharon, Elad
Publication type:
Article
Identification of biologic agents to neutralize the bicomponent leukocidins of Staphylococcus aureus.
Published in:
Science Translational Medicine, 2019, v. 11, n. 475, p. N.PAG, doi. 10.1126/scitranslmed.aat0882
By:
- Chan, Rita;
- Buckley, Peter T.;
- O'Malley, Aidan;
- Sause, William E.;
- Alonzo III, Francis;
- Lubkin, Ashira;
- Boguslawski, Kristina M.;
- Payne, Angela;
- Fernandez, Jeffrey;
- Strohl, William R.;
- Whitaker, Brian;
- Lynch, Anthony Simon;
- Torres, Victor J.
Publication type:
Article

Works matching IS 19466234 AND DT 2019 AND VI 11 AND IP 475

An engineered E. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans.

Targeting hepatic glucokinase to treat diabetes with TTP399, a hepatoselective glucokinase activator.

Clinical-grade stem cell–derived retinal pigment epithelium patch rescues retinal degeneration in rodents and pigs.

Tuberculosis following PD-1 blockade for cancer immunotherapy.

Identification of biologic agents to neutralize the bicomponent leukocidins of Staphylococcus aureus.